common.study.topics.clinical

Testing Experimental Medication in Healthy Subjects

common.study.values.description

A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.

This is an open-label, sequential 2 cohort, intramuscular injection study in healthy volunteers. The study will enroll approximately 24 healthy volunteers to examine the safety, pharmacokinetics, and bioavailability after intramuscular injection of NALDEBAIN ER Injection and nalbuphine injection.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Dinalbuphine sebacate

150 mg Dinalbuphine sebacate

Drug - Nalbuphine HCl

20 mg Nalbuphine

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.

common.study.values.clinical-trial-id

NCT04256434

participant.views.study.view.id

e0R5Gb